Search details
1.
Environmental pollutants and the immune response.
Nat Immunol
; 21(12): 1486-1495, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33046888
2.
The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin.
Nat Immunol
; 18(1): 64-73, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27869817
3.
Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's disease.
Exp Dermatol
; 28(8): 933-939, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31001887
4.
GITR cosignal in ILC2s controls allergic lung inflammation.
J Allergy Clin Immunol
; 141(5): 1939-1943.e8, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29427641
5.
Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease.
Acta Derm Venereol
; 92(6): 625-8, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22949100
6.
Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages.
Exp Dermatol
; 25(5): 397-9, 2016 05.
Article
in English
| MEDLINE | ID: mdl-27167703
7.
Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients.
Front Oncol
; 11: 798385, 2021.
Article
in English
| MEDLINE | ID: mdl-34912726
8.
Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma.
Front Immunol
; 11: 534323, 2020.
Article
in English
| MEDLINE | ID: mdl-33178182
9.
Aryl Hydrocarbon Receptor Modulates Carcinogenesis and Maintenance of Skin Cancers.
Front Med (Lausanne)
; 6: 194, 2019.
Article
in English
| MEDLINE | ID: mdl-31552251
10.
Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies.
Front Med (Lausanne)
; 6: 174, 2019.
Article
in English
| MEDLINE | ID: mdl-31417907
11.
BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trials.
Expert Opin Investig Drugs
; 28(2): 143-148, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30556435
12.
Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection.
Front Med (Lausanne)
; 6: 140, 2019.
Article
in English
| MEDLINE | ID: mdl-31297373
13.
Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.
Front Oncol
; 8: 3, 2018.
Article
in English
| MEDLINE | ID: mdl-29410946
14.
The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.
Anticancer Res
; 38(1): 113-120, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29277763
15.
HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy.
J Dermatol
; 45(6): 735-737, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29488243
16.
Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.
Oncotarget
; 9(21): 15542-15551, 2018 Mar 20.
Article
in English
| MEDLINE | ID: mdl-29643991
17.
Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma.
Front Oncol
; 8: 530, 2018.
Article
in English
| MEDLINE | ID: mdl-30510916
18.
Successful treatment of pigmented dermatofibrosarcoma protuberance on the nasal root with cyberknife radiosurgery.
Acta Derm Venereol
; 92(6): 658-9, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22504888
19.
Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine.
Acta Derm Venereol
; 92(6): 654-5, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22504780
20.
Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.
Anticancer Res
; 37(7): 3461-3471, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28668835